To include your compound in the COVID-19 Resource Center, submit it here.

Syros rises after $50M IPO

Syros Pharmaceuticals Inc. (NASDAQ:SYRS) gained $5.65 (45%) to $18.15 on its first day of trading Thursday after raising

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE